Investor Overview

Pardes is a clinical-stage biopharmaceutical company created by and for this moment to solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to develop novel drugs while reimagining the patient journey to access these medicines.

Stock
Quote

Webcasts

11/15/2022
at 12:00 AM PST
06/09/2022
at 11:30 AM EDT
03/09/2022
at 11:10 AM PST

Financial Information

Document Date Description Form View

A statement of beneficial ownership of common stock by certain persons

SC 13G View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G View HTML

Additional proxy soliciting materials - definitive

DEFA14A View HTML

Amended Registration statement for face-amount certificate companies

S-1/A View HTML

Amended Registration statement for face-amount certificate companies

S-1/A View HTML

Amendment to a previously filed 10-Q

10-Q/A View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Amendment to a previously filed 4

4/A View HTML

Amendment to a previously filed 4

4/A View HTML

Contact
IR

Send us an investor-related question using the form below.